BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 17498669)

  • 1. Involvement of Y(5) receptors in neuropeptide Y agonist-induced analgesic-like effect in the rat hot plate test.
    Thomsen M; Wörtwein G; Olesen MV; Begtrup M; Havez S; Bolwig TG; Woldbye DP
    Brain Res; 2007 Jun; 1155():49-55. PubMed ID: 17498669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential roles for neuropeptide Y Y1 and Y5 receptors in anxiety and sedation.
    Sørensen G; Lindberg C; Wörtwein G; Bolwig TG; Woldbye DP
    J Neurosci Res; 2004 Sep; 77(5):723-9. PubMed ID: 15352219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropeptide Y receptor-expressing dorsal horn neurons: role in nocifensive reflex responses to heat and formalin.
    Wiley RG; Lemons LL; Kline RH
    Neuroscience; 2009 Jun; 161(1):139-47. PubMed ID: 19138726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of neuropeptide Y and Y1 receptor in antinociception in the arcuate nucleus of hypothalamus, an immunohistochemical and pharmacological study in intact rats and rats with inflammation.
    Li JJ; Zhou X; Yu LC
    Pain; 2005 Nov; 118(1-2):232-42. PubMed ID: 16216414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Possible involvement of neuropeptide Y Y1 receptors in antidepressant like effect of agmatine in rats.
    Kotagale NR; Paliwal NP; Aglawe MM; Umekar MJ; Taksande BG
    Peptides; 2013 Sep; 47():7-11. PubMed ID: 23816796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The novel neuropeptide Y Y(1) receptor antagonist J-104870: a potent feeding suppressant with oral bioavailability.
    Kanatani A; Kanno T; Ishihara A; Hata M; Sakuraba A; Tanaka T; Tsuchiya Y; Mase T; Fukuroda T; Fukami T; Ihara M
    Biochem Biophys Res Commun; 1999 Dec; 266(1):88-91. PubMed ID: 10581170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Up-regulation of neuropeptide Y levels and modulation of glutamate release through neuropeptide Y receptors in the hippocampus of kainate-induced epileptic rats.
    Silva AP; Xapelli S; Pinheiro PS; Ferreira R; Lourenço J; Cristóvão A; Grouzmann E; Cavadas C; Oliveira CR; Malva JO
    J Neurochem; 2005 Apr; 93(1):163-70. PubMed ID: 15773916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microinjection of neuropeptide Y into periaqueductal grey produces anti-nociception in rats with mononeuropathy.
    Wang JZ
    Sheng Li Xue Bao; 2004 Feb; 56(1):79-82. PubMed ID: 14985834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The novel neuropeptide Y Y5 receptor antagonist Lu AA33810 [N-[[trans-4-[(4,5-dihydro[1]benzothiepino[5,4-d]thiazol-2-yl)amino]cyclohexyl]methyl]-methanesulfonamide] exerts anxiolytic- and antidepressant-like effects in rat models of stress sensitivity.
    Walker MW; Wolinsky TD; Jubian V; Chandrasena G; Zhong H; Huang X; Miller S; Hegde LG; Marsteller DA; Marzabadi MR; Papp M; Overstreet DH; Gerald CP; Craig DA
    J Pharmacol Exp Ther; 2009 Mar; 328(3):900-11. PubMed ID: 19098165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracerebroventricular administration of 26RFa produces an analgesic effect in the rat formalin test.
    Yamamoto T; Miyazaki R; Yamada T
    Peptides; 2009 Sep; 30(9):1683-8. PubMed ID: 19520126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Galanin-neuropeptide Y (NPY) interactions in central cardiovascular control: involvement of the NPY Y receptor subtype.
    Díaz-Cabiale Z; Parrado C; Rivera A; de la Calle A; Agnati L; Fuxe K; Narváez JA
    Eur J Neurosci; 2006 Jul; 24(2):499-508. PubMed ID: 16903855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of neuropeptide Y in the acute, chronic and withdrawal responses of morphine in nociception in neuropathic rats: behavioral and neuroanatomical correlates.
    Upadhya MA; Dandekar MP; Kokare DM; Singru PS; Subhedar NK
    Neuropeptides; 2009 Aug; 43(4):303-14. PubMed ID: 19556004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The anti-epileptic actions of neuropeptide Y in the hippocampus are mediated by Y and not Y receptors.
    El Bahh B; Balosso S; Hamilton T; Herzog H; Beck-Sickinger AG; Sperk G; Gehlert DR; Vezzani A; Colmers WF
    Eur J Neurosci; 2005 Sep; 22(6):1417-30. PubMed ID: 16190896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropeptide Y modulates the antidepressant activity of imipramine in olfactory bulbectomized rats: involvement of NPY Y1 receptors.
    Goyal SN; Upadhya MA; Kokare DM; Bhisikar SM; Subhedar NK
    Brain Res; 2009 Apr; 1266():45-53. PubMed ID: 19254701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infusion of neuropeptide Y into CA3 region of hippocampus produces antidepressant-like effect via Y1 receptor.
    Ishida H; Shirayama Y; Iwata M; Katayama S; Yamamoto A; Kawahara R; Nakagome K
    Hippocampus; 2007; 17(4):271-80. PubMed ID: 17265460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Possible involvement of supraspinal opioid and GABA receptors in CDP-choline-induced antinociception in acute pain models in rats.
    Hamurtekin E; Bagdas D; Gurun MS
    Neurosci Lett; 2007 Jun; 420(2):116-21. PubMed ID: 17531379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropeptide Y suppresses absence seizures in a genetic rat model primarily through effects on Y receptors.
    Morris MJ; Gannan E; Stroud LM; Beck-Sickinger AG; O'Brien TJ
    Eur J Neurosci; 2007 Feb; 25(4):1136-43. PubMed ID: 17331209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological characterization and appetite suppressive properties of BMS-193885, a novel and selective neuropeptide Y(1) receptor antagonist.
    Antal-Zimanyi I; Bruce MA; Leboulluec KL; Iben LG; Mattson GK; McGovern RT; Hogan JB; Leahy CL; Flowers SC; Stanley JA; Ortiz AA; Poindexter GS
    Eur J Pharmacol; 2008 Aug; 590(1-3):224-32. PubMed ID: 18573246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha-melanocyte stimulating hormone antagonizes antidepressant-like effect of neuropeptide Y in Porsolt's test in rats.
    Goyal SN; Kokare DM; Chopde CT; Subhedar NK
    Pharmacol Biochem Behav; 2006 Oct; 85(2):369-77. PubMed ID: 17052748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropeptide Y Y1 receptors mediate morphine-induced reductions of natural killer cell activity.
    Saurer TB; Ijames SG; Lysle DT
    J Neuroimmunol; 2006 Aug; 177(1-2):18-26. PubMed ID: 16766046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.